Kevin Hornsby, MD
Family Medicine · Defuniak Springs, FLNPI 1619908910
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $548 of the $679 with a category attached, or 80.7%. 12 manufacturers reported payments, led by Lilly USA, LLC at 29.6% of the total. Reporting peaked in 2021 at $282 and has fallen 84.5% since, to $44 in 2023.
Across 29 payments — averaging $23.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$201
- Abbott$161
- Sanofi Pasteur Inc.$131
- Johnson & Johnson$33
- Xeris Pharmaceuticals, Inc.$23
- AbbVie$23
- plus $106 from 6 others
What the payments were for
- Food & beverage$54881%
- Gifts$13119%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 14 | $201 |
| Abbott | 1 | $161 |
| Sanofi Pasteur Inc. | 4 | $131 |
| Johnson & Johnson | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| AbbVie | 1 | $23 |
| Melinta Therapeutics, LLC | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Mylan Specialty L.p. | 1 | $21 |
| Novartis | 1 | $14 |
| Merck | 1 | $13 |
| AstraZeneca | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim IPG$161
How this compares
$679 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 17 | $225 |
| Metoprolol Succinate | 13 | $209 |
| Lisinopril | 11 | $181 |
| Atorvastatin Calcium | 17 | $180 |
| Dicyclomine Hcl | 12 | $175 |
| Levothyroxine Sodium | 21 | $153 |
| Cephalexin | 13 | $138 |
| Methocarbamol | 12 | $74 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $72 |
| Azithromycin | 24 | $69 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $56 |
| Donepezil Hcl | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Defuniak Springs
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
- Louis KuritzkyGainesville$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.